Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2011

01-03-2011 | Translational Research and Biomarkers

Epithelial–Mesenchymal Transition and LOXL2: Consideration Continues

Authors: Dajiang Li, PhD, Tianyu Li, PhD, Shuguang Wang, PhD

Published in: Annals of Surgical Oncology | Issue 3/2011

Login to get access

Excerpt

We appreciate the interest in our recent publication in the Annals of Surgical Oncology.1 We thank Clara Balsano and colleagues for their comments. …
Literature
1.
2.
Peng L, Ran YL, Hu H, Yu L, Liu Q, Zhou Z, et al. Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway. Carcinogenesis. 2009;30:1660–9.PubMedCrossRef
3.
Peinado H, Moreno-Bueno G, Hardisson D, Pérez-Gómez E, Santos V, Mendiola M, et al. Lysyl oxidase–Like 2 as a new poor prognosis marker of squamous cell carcinomas. Cancer Res. 2008;68:4541–50.PubMedCrossRef
4.
Hollosi P, Yakushiji JK, Fong KS, Csiszar K, Fong SF. Lysyl oxidase-like 2 promotes migration in noninvasive breast cancer cells but not in normal breast epithelial cells. Int J Cancer. 2009;125:318–27.PubMedCrossRef
Metadata
Title
Epithelial–Mesenchymal Transition and LOXL2: Consideration Continues
Authors
Dajiang Li, PhD
Tianyu Li, PhD
Shuguang Wang, PhD
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 3/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1216-8

Other articles of this Issue 3/2011

Annals of Surgical Oncology 3/2011 Go to the issue

Melanomas

Lymphadenectomy for Melanoma: Toward a Videoscopic Approach

Bone and Soft Tissue Sarcomas

Myxofibrosarcoma: Prognostic Factors and Survival in a Series of Patients Treated at a Single Institution

Colorectal Cancer

Loss of E-cadherin and MUC2 Expressions Correlated with Poor Survival in Patients with Stages II and III Colorectal Carcinoma

Gastrointestinal Oncology

An Elevated Body Mass Index Does Not Reduce Survival After Esophagectomy for Cancer

Colorectal Cancer

2010 SSO John Wayne Clinical Research Lecture: Rectal Cancer Outcome Improvements in Europe: Population-Based Outcome Registrations will Conquer the World

Pancreatic Tumors

Borderline Resectable Pancreatic Cancer: What Have We Learned and Where Do We Go From Here?